Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MariMed Inc. (MRMD : OTC)

• Company Description    MariMed Inc. is a multi-state cannabis operator. The Company develops, owns and manages seed to sale state-licensed cannabis facilities, which are models in horticultural principles, cannabis cultivation, cannabis-infused products and dispensary operations. Its products and brands, includes Betty's Eddies(R), Nature's Heritage(TM), Bourne Baking Co. and K-Fusion(R). MariMed Inc. is based in NORWOOD, Mass. Number of Employees: 326

• Price / Volume Information    Yesterday's Closing Price: $0.63 Daily Weekly Monthly 20 Day Moving Average: 517,180 shares Shares Outstanding: 338.14 (millions) Market Capitalization: $212.25 (millions) Beta: 3.27 52 Week High: $1.20 52 Week Low: $0.55 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.82% -4.86% 12 Week -20.12% -15.90% Year To Date -27.43% -15.41%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10 Oceana Way - Norwood,MA 02062 USA ph: 617-795-5140 fax: - ir@mattio.com http://www.marimedinc.com

• General Corporate Information    Officers Robert Fireman - Chief Executive Officer;Chairman and President Jon R. Levine - Chief Financial Officer; Treasurer; Secretary; and Eva Selhub - Director David Allen - Director Edward Gildea - Director Peer Information MariMed Inc. (BJCT) MariMed Inc. (CADMQ) MariMed Inc. (APNO) MariMed Inc. (UPDC) MariMed Inc. (IMTIQ) MariMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 56782V107 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/15/22 Share - Related Items Shares Outstanding: 338.14 Most Recent Split Date: (:1) Beta: 3.27 Market Capitalization: $212.25 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.05 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/15/22

• Fundamental Ratios P/E Current FY Estimate: 12.55 Trailing 12 Months: 31.39 PEG Ratio: - Price Ratios Price/Book: 4.84 Price/Cash Flow: 8.39 Price / Sales: 1.66 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 150.00% Sales Growth vs. Year Ago Period: 26.94% vs. Previous Quarter: 0.77% ROE 03/31/22 - 20.87 12/31/21 - 26.74 09/30/21 - 87.05 ROA 03/31/22 - 6.07 12/31/21 - 6.84 09/30/21 - 18.61 Current Ratio 03/31/22 - 1.59 12/31/21 - 1.64 09/30/21 - 2.22 Quick Ratio 03/31/22 - 1.23 12/31/21 - 1.28 09/30/21 - 1.73 Operating Margin 03/31/22 - 5.70 12/31/21 - 6.11 09/30/21 - 16.28 Net Margin 03/31/22 - 5.70 12/31/21 - 6.04 09/30/21 - 16.12 Pre-Tax Margin 03/31/22 - 20.45 12/31/21 - 19.61 09/30/21 - 26.46 Book Value 03/31/22 - 0.13 12/31/21 - 0.11 09/30/21 - 0.11 Inventory Turnover 03/31/22 - 5.50 12/31/21 - 5.90 09/30/21 - 5.61 Debt-to-Equity 03/31/22 - 0.39 12/31/21 - 0.48 09/30/21 - 0.51 Debt-to-Capital 03/31/22 - 42.16 12/31/21 - 32.26 09/30/21 - 33.68

Powered by Zacks Investment Research ©